相关实验视频

Updated: Jul 17, 2025

Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair

Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair

Published on: September 7, 2017

经过工程改造的简短形式的珀莱干通过增强生长因子信号的强化来增强血管生成

Ha Na Kim¹, Zehra Elgundi², Xiaoting Lin²

¹Graduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW 2052, Australia; Molecular Surface Interaction Laboratory, Analytical Centre, University of New South Wales, Sydney, NSW 2052, Australia.

Journal of controlled release : official journal of the Controlled Release Society

|August 30, 2023

概括

基托支架中的工程片段可以增强血管生长 (血管生成). 这种新的方法通过增强组织修复和再生疗法的生长因子来改善愈合.

科学领域:

生物材料科学生物材料科学
再生医学是一种再生医学.
分子生物学分子生物学

背景情况:

血管新生对于组织修复至关重要,但生长因子的输送在临床上取得了有限的成功.
增长因子与细胞外基质 (ECM) 相互作用,特别是肝素硫酸盐 (HS),以调节信号传输.
珀莱干是一种主要的血管ECM HS蛋白质糖,影响生长因子活性.

研究的目的:

调查工程短形式的perlecan用于增强的血管新生疗法.
评估工程的结合和信号与关键的血管生长因子.
为了评估充满perlecan的奇托桑支架在促进活体血管生成中的有效性.

主要方法:

设计和合成了工程短形状.
用纤维细胞生长因子2 (FGF2) 和血管内皮生长因子-A (VEGF-A) 进行了结合和信号测试.
装有珀莱肯的多孔基托桑支架被植入大鼠皮肤伤口模型中,以评估血管生成.

主要成果:

经过工程设计的虫碎片成功结合并发出了血管性生长因子 (FGF2,VEGF-A) 的信号.
带有珀莱干的奇托桑支架在老鼠伤口模型中显著促进了血管新生.
与对照组相比,perlecan域I和V的融合显示出更高的血管化.

结论:

经过工程设计的短珀莱肯形式显示出作为下一代血管新生疗法的潜力.
装有工程的基托桑支架通过增强生长因子来提高治疗效果.
这种方法提供了一种有希望的策略,通过增强血管生成来改善组织修复和再生.

关键词:

血管新生的产生.生物材料是一种生物材料.增长因子增长因子珀莱莱肯 (Perlecan) 是一个巨人.血管化的情况.伤口愈合伤口愈合

更多相关视频

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Published on: June 30, 2023

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Published on: September 27, 2013

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...